Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220150560111728
Journal of the Korean Ophthalmological Society
2015 Volume.56 No. 11 p.1728 ~ p.1735
Short-Term Efficacy of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
¾çÇå:Yang Heon
ÀüÇý¹Î:Jeon Hye-Min/±è»ó¿ø:Kim Sang-Won/À±Èñ¼º:Yoon Hee-Sung/ÃÖ¿ì¼®:Choi Woo-Seok
Abstract
Purpose: To evaluate the short-term effect of intravitreal aflibercept (Eylea¨Þ; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA and Bayer, Basel, Switzerland) on the visual outcomes and retinal anatomic changes of patients with polypoidal choroidal vasculopathy (PCV).

Methods: Intravitreal Eylea¨Þ was injected into 16 eyes of 16 patients with PCV in this retrospective case study. After therapy, the patients were followed up for over 3 months. Changes in best-corrected visual acuity (BCVA) and central foveal thickness (CFT) using optical coherence tomography (OCT) and abnormal vasculature on indocyanine green angiography (ICGA) were evaluated.

Results: The mean log MAR BCVA was 0.75 ¡¾ 0.60 at baseline, 0.74 ¡¾ 0.60 and 0.71 ¡¾ 0.63 at 1 and 2 months, respectively (p > 0.05) and 0.57 ¡¾ 0.53 at 3 months (p < 0.05) after treatment. The mean CFT was 379 ¡¾ 130 ¥ìm at baseline, 281 ¡¾ 92 ¥ìm, 247 ¡¾ 54 ¥ìm, and 231 ¡¾ 51 ¥ìm at 1, 2, and 3 months, respectively, after treatment (p < 0.05). Complete resolution was 43%, 55%, and 50% at 1, 2, and 3 months, respectively in pigment epithelial detachment (PED), 67%, 83%, and 92% at 1, 2, and 3 months, respectively in subretinal fluid (SRF) and 33%, 60%, and 60% at 1, 2, and 3 months, respectively in intraretinal fluid (IRF) using OCT. The polypoidal lesions in ICGA decreased in 12 of 14 eyes (86%).

Conclusions: Intravitreal injection of Eylea¨Þ with PCV reduced CFT due to decreased retinal PED, SRF, IRF and occluded effectively the polypoidal lesion leaking. Compared with baseline, mean BCVA at the 3-month follow-up was significantly improved.
KEYWORD
Aflibercept, Intravitreal injection, Polypoidal choroidal vasculopathy
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø